Drugs / DTPw-HBV/Hib-MenAC conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00290303 | May 2004 → Mar 2005 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPw-HBV/Hib-MenAC conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00290303 ↗ |
| Modality | Vaccine | “DTPw-HBV/Hib-MenAC conjugate vaccine” NCT00290303 ↗ |